Form 13-F position report

EYEGATE PHARMACEUTICALS INC

Reported by Bank of America Corporation

KPHMW CUSIP 30233M107 Manager CIK 0000070858

Reported 0 shares, down 24 (100.0%) from the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2017
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 2 Through Q4 2017

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for EYEGATE PHARMACEUTICALS INC held by Bank of America Corporation.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

18 managers reported EYEGATE PHARMACEUTICALS INC for Q4 2017.

Managers reporting EYEGATE PHARMACEUTICALS INC in Q4 2017.
Manager Activity Shares Change % of reported 13F Reported value Tenure
ARMISTICE CAPITAL LLC Reduced 1,284,000 -332,000 0.14% $1,374,000 3 qtrs
VANGUARD GROUP INC Unchanged 268,119 0 < 0.01% $287,000 9 qtrs
Virtu Financial LLC Added 71,910 +55,943 < 0.01% $77,000 2 qtrs
CITADEL ADVISORS LLC New 32,169 +32,169 < 0.01% $34,000 1 qtr
TWO SIGMA SECURITIES LLC Reduced 30,483 -1,539 < 0.01% $33,000 4 qtrs
MACQUARIE GROUP LTD New 25,400 +25,400 < 0.01% $27,000 1 qtr
IFP Advisors Inc Reduced 23,800 -2,000 < 0.01% $25,000 6 qtrs
CREDIT SUISSE AG Reduced 20,000 -10,000 < 0.01% $21,000 2 qtrs
WEDBUSH SECURITIES INC New 20,000 +20,000 < 0.01% $21,000 1 qtr
NORTHERN TRUST CORPORATION Added 14,553 +3,276 < 0.01% $16,000 2 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2017
Filed
February 14, 2018
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.